arrow
J

Jérôme Bertherat

cochin hospital
H指数:105
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EP1075 - ECE_1915 - Quality-of-life improvements in patients with Cushing's syndrome: results from an ad hoc analysis of new osilodrostat users in a prospective, non-interventional study (LINC 6)

EP1075 - ECE_1915 - 库欣综合征患者的生活质量改善:前瞻性、非干预性研究(LINC 6)中新使用奥西洛多司患者的临时分析结果

2026-08-100
OAAI
P272 - ECE_1911 - LINC 7 secondary analysis: osilodrostat treatment outcomes across various aetiologies and severities of Cushing's syndrome

P272 - ECE_1911 - LINC 7 二次分析:奥西洛司特治疗各种病因和严重程度的库欣综合征的疗效

2026-08-100
OAAI
OC6.5 - ECE_3441 - Transcriptome signatures associated with response to treatment in advanced adrenocortical carcinoma

OC6.5 - ECE_3441 - 与治疗反应相关的转录组特征在晚期肾上腺皮质癌中的应用

2026-08-100
OAAI
RC9.3 - ECE_1649 - Cortisol and steroids circadian variations are higher in Cushing syndrome patients treated with metyrapone than osilodrostat and follow daily drug levels fluctuations

RC9.3 - ECE_1649 - 皮质醇和类固醇昼夜节律变化在服用美替拉酮的库欣综合征患者中高于服用奥西洛朵司他者,并随每日药物水平波动而变化

2026-08-100
OAAI
EP138 - ECE_2888 - Higher frequency of meningiomas in patients with pathogenic variants of the ARMC5 gene predisposing to primary bilateral macronodular adrenal hyperplasia

EP138 - ECE_2888 - ARMC5基因致病变异易感原发性双侧大结节性肾上腺增生患者中脑膜瘤的高发频率

2026-08-100
OAAI
P280 - ECE_1603 - Ketoconazole ESTEVE in endogenous Cushing’s syndrome: post-authorisation safety study in 132 patients

P280 - ECE_1603 - ESTEVE Ketoconazole在内源性库欣综合征中的安全性研究:132例患者的上市后安全性研究

2026-08-100
OAAI
Integrated clinical–genetic–pathological analysis expands the phenotypic and molecular spectrum of PPNAD across carney complex and isolated forms

整合临床-遗传-病理学分析扩展了Carney复合征和孤立型PPNAD的表型和分子谱

2026-08-030
PRE
The Proteome of Bilateral Macronodular Adrenocortical Disease (BMAD) Shows Different Profiles Correlating with the Genetic Causes and Reveals Specific Dysregulation of RNA Polymerase II and Cholesterol Biosynthesis Enzymes
2026-01-120
PRE
PRKACA constitutional duplication: a specific cause of primary pigmented nodular adrenocortical disease
2025-12-010
PRE
Real-World Osilodrostat Effectiveness and Safety in Nonpituitary Cushing Syndrome

真实世界中非垂体库欣综合征奥西洛司特的有效性和安全性

2025-12-010
PRE
Impact of steroid differentiation on tumor microenvironment revealed by single-nucleus atlas of adrenal tumors

类固醇分化对肾上腺肿瘤微环境的影响:单核图谱揭示

2025-10-060
OAAI
Transcriptomic classification of prolactinomas and somatotropinomas identifies subtypes with variable resistance to treatment

垂体泌乳素瘤和生长激素腺瘤的转录组分类鉴定出具有不同治疗抵抗性的亚型

2025-10-010
PRE
A Global Approach to the Long-Term Follow-Up of 17 Families With Bilateral Macronodular Adrenal Disease
2025-09-010
PRE
Fluctuations in diurnal plasma cortisol cycle in patients treated with metyrapone or osilodrostat for endogenous Cushing syndrome

接受美替拉酮或奥西洛drostat治疗的内源性库欣综合征患者昼夜血浆皮质醇循环的波动

2025-09-010
OAAI